Matches in SemOpenAlex for { <https://semopenalex.org/work/W2332890129> ?p ?o ?g. }
- W2332890129 endingPage "2268" @default.
- W2332890129 startingPage "2258" @default.
- W2332890129 abstract "The synthesis of the 8 possible stereoisomeric diol epoxides (DEs) at the terminal benzo ring of carcinogenic dibenz[a,h]anthracene (DBA) is reported. trans-3,4-Dihydroxy-3,4-dihydro-DBA (1) afforded the 4 bay region DEs: the enantiomeric pairs of the anti diastereomers (+)-3/(−)-3 and of the syn diastereomers (−)-4/(+)-4, respectively. trans-1,2-Dihydroxy-1,2-dihydro-DBA (2) served as precursor of the 4 reverse DEs: the enantiomeric pairs of the anti diastereomers (+)-5/(−)-5 and of the syn diastereomers (−)-6/(+)-6, respectively. The transformation of the olefinic double bond in the enantiomeric trans-dihydrodiols to epoxides was achieved by either (i) oxidation with m-chloroperoxybenzoic acid or (ii) formation of a bromohydrin with N-bromoacetamide/H2O followed by dehydrobromination with an anion exchange resin. Because of the pseudodiequatorial conformation of the hydroxyl groups in 1, both reactions proceeded highly stereoselectively, while the stereoselectivity was impaired by the pseudodiaxial conformation of the hydroxyl groups in 2. Diastereomers and racemic compounds were efficiently separated without derivatization by HPLC on achiral or chiral stationary phases, respectively. The absolute configurations of the DEs were deduced from the absolute configuration of 1 and 2 considering the regio- and stereoselectivity of the subsequent reactions and resulted in (+)-(1R,2S,3S,4R)-3/(−)-(1S,2R,3R,4S)-3, (−)-(1S,2R,3S,4R)-4/(+)-(1R,2S,3R,4S)-4, (+)-(1R,2S,3S,4R)-5/(−)-(1S,2R,3R,4S)-5, and (−)-(1R,2S,3R,4S)-6/(+)-(1S,2R,3S,4R)-6. The bacterial mutagenicity of the 8 stereoisomeric DEs was determined in histidine-dependent strains TA98 and TA100 of Salmonella typhimurium in the absence of a metabolizing system. In general, the bay region DEs of DBA were stronger mutagens than the reverse DEs. In strain TA98, the syn diastereomers of bay region DEs were stronger mutagens than their anti isomers, while in the case of reverse DEs the anti diastereomers were more potent than their syn isomers. In strain TA100, all syn diastereomers surpassed the bacterial mutagenicity of their anti isomers. Concerning the bay region DEs of DBA, this corresponds to the situation described for benzo[a]pyrene: of the 4 enantiomeric bay region DEs of DBA and benzo[a]pyrene, the syn diastereomer with [(R,S)-diol (R,S)-epoxide] absolute configuration is the most potent mutagen in both bacterial strains, while the anti isomer with [(S,R)-diol (R,S)-epoxide] configuration is the weakest mutagen." @default.
- W2332890129 created "2016-06-24" @default.
- W2332890129 creator A5001200824 @default.
- W2332890129 creator A5010639425 @default.
- W2332890129 creator A5046143290 @default.
- W2332890129 creator A5074127811 @default.
- W2332890129 date "2011-11-16" @default.
- W2332890129 modified "2023-09-25" @default.
- W2332890129 title "Synthesis, Absolute Configuration, and Bacterial Mutagenicity of the 8 Stereoisomeric Vicinal Diol Epoxides at the Terminal Benzo Ring of Carcinogenic Dibenz[<i>a,h</i>]anthracene" @default.
- W2332890129 cites W1965629864 @default.
- W2332890129 cites W1966308947 @default.
- W2332890129 cites W1967957601 @default.
- W2332890129 cites W1970760147 @default.
- W2332890129 cites W1972727374 @default.
- W2332890129 cites W1973195696 @default.
- W2332890129 cites W1974074449 @default.
- W2332890129 cites W1974120200 @default.
- W2332890129 cites W1974648730 @default.
- W2332890129 cites W1982480665 @default.
- W2332890129 cites W1993430721 @default.
- W2332890129 cites W1993557939 @default.
- W2332890129 cites W1994838511 @default.
- W2332890129 cites W1995131475 @default.
- W2332890129 cites W2005156172 @default.
- W2332890129 cites W2006901186 @default.
- W2332890129 cites W2012410948 @default.
- W2332890129 cites W2041574837 @default.
- W2332890129 cites W2055847312 @default.
- W2332890129 cites W2057454914 @default.
- W2332890129 cites W2057740999 @default.
- W2332890129 cites W2065515991 @default.
- W2332890129 cites W2066013255 @default.
- W2332890129 cites W2068575533 @default.
- W2332890129 cites W2071063474 @default.
- W2332890129 cites W2073325168 @default.
- W2332890129 cites W2082393291 @default.
- W2332890129 cites W2085875292 @default.
- W2332890129 cites W2091311321 @default.
- W2332890129 cites W210134649 @default.
- W2332890129 cites W2102382467 @default.
- W2332890129 cites W2156101444 @default.
- W2332890129 cites W2188702955 @default.
- W2332890129 cites W2501820592 @default.
- W2332890129 cites W3004447210 @default.
- W2332890129 cites W3004773992 @default.
- W2332890129 cites W3005477962 @default.
- W2332890129 doi "https://doi.org/10.1021/tx200398b" @default.
- W2332890129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22087540" @default.
- W2332890129 hasPublicationYear "2011" @default.
- W2332890129 type Work @default.
- W2332890129 sameAs 2332890129 @default.
- W2332890129 citedByCount "3" @default.
- W2332890129 countsByYear W23328901292013 @default.
- W2332890129 countsByYear W23328901292014 @default.
- W2332890129 countsByYear W23328901292023 @default.
- W2332890129 crossrefType "journal-article" @default.
- W2332890129 hasAuthorship W2332890129A5001200824 @default.
- W2332890129 hasAuthorship W2332890129A5010639425 @default.
- W2332890129 hasAuthorship W2332890129A5046143290 @default.
- W2332890129 hasAuthorship W2332890129A5074127811 @default.
- W2332890129 hasConcept C138716334 @default.
- W2332890129 hasConcept C161790260 @default.
- W2332890129 hasConcept C178790620 @default.
- W2332890129 hasConcept C181647583 @default.
- W2332890129 hasConcept C185592680 @default.
- W2332890129 hasConcept C25170562 @default.
- W2332890129 hasConcept C2776920199 @default.
- W2332890129 hasConcept C2779515768 @default.
- W2332890129 hasConcept C2779563022 @default.
- W2332890129 hasConcept C2780378348 @default.
- W2332890129 hasConcept C486523 @default.
- W2332890129 hasConcept C71240020 @default.
- W2332890129 hasConceptScore W2332890129C138716334 @default.
- W2332890129 hasConceptScore W2332890129C161790260 @default.
- W2332890129 hasConceptScore W2332890129C178790620 @default.
- W2332890129 hasConceptScore W2332890129C181647583 @default.
- W2332890129 hasConceptScore W2332890129C185592680 @default.
- W2332890129 hasConceptScore W2332890129C25170562 @default.
- W2332890129 hasConceptScore W2332890129C2776920199 @default.
- W2332890129 hasConceptScore W2332890129C2779515768 @default.
- W2332890129 hasConceptScore W2332890129C2779563022 @default.
- W2332890129 hasConceptScore W2332890129C2780378348 @default.
- W2332890129 hasConceptScore W2332890129C486523 @default.
- W2332890129 hasConceptScore W2332890129C71240020 @default.
- W2332890129 hasIssue "12" @default.
- W2332890129 hasLocation W23328901291 @default.
- W2332890129 hasLocation W23328901292 @default.
- W2332890129 hasOpenAccess W2332890129 @default.
- W2332890129 hasPrimaryLocation W23328901291 @default.
- W2332890129 hasRelatedWork W1972272489 @default.
- W2332890129 hasRelatedWork W1981969905 @default.
- W2332890129 hasRelatedWork W2043970642 @default.
- W2332890129 hasRelatedWork W2045928316 @default.
- W2332890129 hasRelatedWork W2122097276 @default.
- W2332890129 hasRelatedWork W2315068946 @default.
- W2332890129 hasRelatedWork W2950663425 @default.
- W2332890129 hasRelatedWork W2951136615 @default.
- W2332890129 hasRelatedWork W1966737042 @default.